HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Robert M Miller Selected Research
Robert M Miller Research Topics
Disease
3
Malaria
10/2022 - 02/2013
1
Pain (Aches)
10/2022
1
Breast Neoplasms (Breast Cancer)
10/2022
1
Neurodevelopmental Disorders
12/2021
1
Fragile X Syndrome (Martin Bell Syndrome)
12/2021
1
Intellectual Disability (Idiocy)
12/2021
1
Polyps
04/2021
1
Papilloma (Papillomatosis)
04/2021
1
COVID-19
08/2020
1
Fever (Fevers)
02/2016
1
Acute malaria
02/2013
1
Vivax Malaria
02/2013
1
Heart Failure
03/2009
1
Dyspnea (Shortness of Breath)
03/2009
1
Chronic Obstructive Pulmonary Disease (COPD)
03/2009
1
Reperfusion Injury
01/2002
Drug/Important Bio-Agent (IBA)
2
artemisinin (artemisinine)
IBA
10/2022 - 02/2016
2
artesunate drug combination pyronaridine tetraphosphate
IBA
02/2016 - 02/2013
1
Aromatase Inhibitors
IBA
10/2022
1
Letrozole (Femara)
FDA Link
Generic
10/2022
1
Hormones (Hormone)
IBA
10/2022
1
exemestane (Aromasin)
FDA Link
10/2022
1
taxane
IBA
10/2022
1
Fragile X Mental Retardation Protein
IBA
12/2021
1
Aerosols
IBA
08/2020
1
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
02/2016
1
Bilirubin
IBA
02/2016
1
Antimalarials (Antimalarial Agents)
IBA
02/2016
1
Alanine Transaminase (SGPT)
IBA
02/2016
1
Natriuretic Peptides
IBA
03/2009
1
pro-brain natriuretic peptide (1-76)
IBA
03/2009
1
adhesion receptor
IBA
01/2002
1
Integrins
IBA
01/2002
Therapy/Procedure
1
Time-to-Treatment
10/2022
1
Therapeutics
10/2022
1
Drug Therapy (Chemotherapy)
12/2021
1
Lasers (Laser)
04/2021
1
Aftercare (After-Treatment)
02/2016